See also this year's filing and all EDGAR filings for this company.
PDF Report 0001599298_2026_Summit_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001599298, Summit Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 720,301,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,001,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,059,000 |
| 3 | remainder_Assets | 27,821,000 |
| 4 | LiabilitiesCurrent | 72,988,000 |
| 5 | LiabilitiesNoncurrent | 19,334,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,036,599,088 |
| 9 | ResearchAndDevelopmentExpense | 2,469,565,790 |
| 10 | remainder_Expenses | 7,724,220 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 15,095,960 |
| 13 | remainder_ComprehensiveNetIncome | -254,146 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 751,182,000 |
| 1 | Liabilities | 92,322,000 |
| 2 | Expenses | 5,513,889,098 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 658,860,000 |
| 5 | NetIncome | -5,498,793,138 |
| 6 | ComprehensiveNetIncome | -5,498,920,211 |
| 7 | BaseVar | 3,186,371,602 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -9.63 |
| 9 | EconomicCapitalRatio | 0.000842 |
Edgar->Model Mapping
Feature Distribution
Change over Time
